Search results for: England

The changing role of the NHS over time

14 August 2023

…Office for National Statistics, 2023. Death registration summary statistics, England and Wales. [online] Available at: https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/articles/deathregistrationsummarystatisticsenglandandwales/2022 [Accessed 10 Aug. 2023]. Office of Health Economics, 1964. New Frontiers in Health. Series…

Reimagining Prevention for a Healthier, More Prosperous Society

29 November 2023, 3:00pm

…NHSA is a northern body working at a national and international level for the health and wealth benefit of Northern England. Hannah has also co-authored several seminal reports, including the…

2022 OHE Annual Report to the Charity Commission

30 November 2023

Share this: Download publication This is the sixth report to the Charity Commission for England and Wales since becoming a registered charity in December 2016. Share this: Download publication This…

Looking Further Afield – What Can Health Economics Learn from the Environmental Economics Approach to Discounting?

1 February 2024

…Institute for Health and Care Excellence (NICE) in England usually discount at a rate of 3.5% (see box 1), but state a lower 1.5% non-reference case rate may be applied…

An Analysis of NICE’s Optimised Decisions from 2015 to 2024

1 May 2025

…within the National Health Service (NHS) in England. Key takeaways High Proportion of Optimised Decisions: NICE categorises 84% of its recommendations as positive, but 36% of these positive decisions since…

Terms and Conditions

…Economics (“OHE” or “We”). The Office of Health Economics (OHE) (registered number 09848965) and OHE Consulting Ltd (a registered company number 09853113) are companies limited by guarantee registered in England and Wales.  Both companies are registered office…

Mental Handicap: Partnership in the Community?

1 July 1986

…this topic (OHE 1973, 1978). The study relates mainly to the situation in England, although some reference is also made to the levels of provision in other parts of Britain….

Learnings from the Assessments of Entrectinib and Larotrectinib: Health Technology Assessment Challenges Associated with Tumour-Agnostic Therapies

1 January 2022

…(HTA) agency determines how these challenges are currently addressed. This report provides an analysis of HTA agency assessments and reimbursement decisions for entrectinib and larotrectinib across England, Germany, France, Canada,…

Are Recommendations for HTA of Gene Therapies Being Achieved?

11 September 2023

…develop country scorecards exploring the extent to which these recommendations are being achieved in eleven countries. The countries considered were: Australia, Canada, Denmark, England, France, Germany, Italy, the Netherlands, Spain,…